4//SEC Filing
Rawlins Michael 4
Accession 0001209191-22-036380
CIK 0001567514other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 5:06 PM ET
Size
5.2 KB
Accession
0001209191-22-036380
Insider Transaction Report
Form 4
Rawlins Michael
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-09+16,757→ 16,757 totalExercise: $55.48From: 2023-06-09Exp: 2032-06-08→ Common Stock (16,757 underlying)
Documents
Issuer
Intra-Cellular Therapies, Inc.
CIK 0001567514
Entity typeother
Related Parties
1- filerCIK 0001585670
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 5:06 PM ET
- Size
- 5.2 KB